7.79 USD
↘ 3.56 (31.40%)LIVE (AS OF 02:44 PM EDT)
Corbus Pharmaceuticals Holdings, Inc.
CRBPNASDAQ • USD
Market: OPEN
Open?$9.75
High?$12.75
Low?$7.77
Prev. Close?$11.35
Volume?2.9M
Avg. Volume?317.7K
VWAP?$8.64
Rel. Volume?9.21x
Bid / Ask
Bid?$7.00 × 100
Ask?$9.23 × 100
Spread?$2.23
Midpoint?$8.12
Valuation & Ratios
Market Cap?210.3M
Shares Out?18.5M
Float?15.9M
Float %?89.7%
P/E Ratio?N/A
P/B Ratio?1.66
EPS?-$4.56
Dividend?0.00%
Ex-Dividend?N/A
Shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP) are trading at $7.79. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest CRBP is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of May 26, 2026.
News
Profile
Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
Themes
Employees
36
Market Cap
210.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-10-24
Address
500 RIVER RIDGE DRIVE
NORWOOD, MA 02062
Phone: 617-963-0103
NORWOOD, MA 02062
Phone: 617-963-0103
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?4
Momentum?23
Short Sent.?60
Piotroski F-Score?0/9Weak
Altman Z-Score?0.34Distress
Confidence?48%Low
Short InterestElevated
Short % of Float?8.85%Elevated
Short Interest?1.4M
Days to Cover?4.6
Free Float15.9M
Avg Daily Volume305.2K
Settlement Date2026-04-30
Financial Health
Current Ratio?7.89Strong
Quick Ratio?7.89Strong
Cash Ratio?1.41Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.66CHEAP▾
Peers100
S&P83
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-66.9%WEAK▾
S&P3
ROA?-58.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-73654000
Enterprise Value?$184.6M
Fundamentals ratios updated end of day